张灵敏博士为药学院教授、博士
/
硕士生导师。
2017
年起,在广州医科大学从事生物医药的整合研
究,围绕重大慢病开展药物研发的新机制、新靶点、新技术、新应用的原创性探索开展工作。已获国
家自然科学基金面上/青年项目、广东省教育厅重点领域项目、广东省自然科学基金面上项目、广州市
科技计划项目等资助,主要研究方向为表观遗传调控、基因治疗、新型药物递送系统。近五年来,相
关研究成果以第一/通讯作者身份发表在 Angewandte Chemie International Edition、Molecular Cancer 和
Advanced Science 等国际知名刊物(共 20 余篇,单篇影响因子最高为 41)。相关成果获授权专利 5 项、
第
48
届日内瓦国际发明展金奖和
2021
年发明创业奖创新奖。当前,张博士获广州市高层次人才称号
(青年后备),担任中国药理学会心血管药理专业委员会第二届青年委员会常务委员、广东省药理学
会第二届心血管药理专业委员会常务委员、中国药理学会首届千人新苗青年委员、《中国组织工程研
究》杂志社医工融合联盟第一届委员,
Frontiers in Chemistry
客座副主编、
Journal of Exploratory Research
in Pharmacology
编委。
1. Zhang L, Lin Y, Li S, et al. In situ reprogramming of tumor-associated macrophages with internally
and externally engineered exosomes [J]. Angewandte Chemie International Edition, 2023, 62, e202217089.
2. Liang L, Cen H, Huang J, et al. The reversion of DNA methylation-induced miRNA silence via
biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy [J]. Molecular
Cancer, 2022, 21, 186.
3. Zhang HT, Peng R, Chen S, et al. Versatile nano-PROTAC-induced epigenetic reader degradation for
efficient lung cancer therapy [J]. Advanced Science, 2022, 2202039.
4. Zhang L, Wang L, Xie Y, et al. Triple-targeting delivery of CRISPR/Cas9 to reduce the risk of
cardiovascular diseases [J]. Angewandte Chemie International Edition, 2019, 58, 12404-12408.
5. Zhang Y, Yang L, Huang J, et al. Bioinspired metal-organic frameworks mediated efficient delivery
of siRNA for cancer therapy [J]. Chemical Engineering Journal, 2021, 19, 131926.
6. Zhang L, Li Y, Chen Q, et al. The construction of drug-resistant cancer cell lines by CRISPR/Cas9
system for drug screening [J]. Science Bulletin, 2018, 63, 1411-1419.
7. Zhang L, Zheng W, Tang R, et al. Gene regulation with carbon-based siRNA conjugates for cancer
therapy [J]. Biomaterials, 2016, 104, 269-278.
8. Zhang L, Deng S, Zhang Y, et al. Homotypic targeting delivery of siRNA with artificial cancer cells
[J]. Advanced Healthcare Materials, 2020, 9, 1900772.
9. Zhang Y, Qin Y, Li H, et al. Artificial platelets for efficient siRNA delivery to clear "bad cholesterol"
[J]. ACS Applied Materials & Interfaces, 2020, 12, 28034-28046.
10. Lin Y, Li S, Xiao Z, et al. Epigenetic inhibition assisted chemotherapeutic treatment of lung cancer
based on artificial exosomes [J]. Pharmacological Research, 2021, 171, 105787.